Design
An observational cohort study was performed between 2015 and 2022. All patients intended to undergo RAL surgery for any stage of endometrial cancer as part of routine care at the Royal Marsden Hospital or any other hospital of the Southwest Thames Gynaecological Cancer Centre we operated in due to capacity constraints were included. All surgeries were performed by three robot-trained gynaecological oncology surgeons. Three generations of Da Vinci robots were used (S, Si, Xi).
Inclusion criteria were women diagnosed with endometrial cancer and the intention of performing RAL hysterectomy, bilateral salpingo-oophorectomy and/or any lymph node dissection. Patients with non-endometrial primary histology or any additional cancer were excluded from analysis.